ent of
leadership, mission and strategy, and strengthening of the fundraising,
partnerships and collaboration, advocacy and communications functions. Key
initiatives include: the development of "new philanthropy" models that have
yielded nearly $10 million to date; the creation of a new graphic identity
and website for Sabin
(http://www.sabin.org); and the establishment of three,
distinct centers to more clearly define Sabin's "diseases of poverty"
mission-Center for Antipoverty Vaccine Development, Center for NTD Control
and Elimination and Center for Antipoverty Vaccine Advocacy.
About the Clinton Global Initiative (CGI)
The Clinton Global Initiative (http://www.clintonglobalinitiative.org) is a
non-partisan catalyst for action, bringing together a community of global
leaders to devise and implement innovative solutions to some of the world's
most pressing challenges. The Clinton Global Initiative is a project of the
William J. Clinton Foundation (http://www.clintonfoundation.org).
About MWW Group
In 2006, MWW Group was named PR Agency of the Year by The Holmes Report
and Mid-size PR Firm of the Year by PR News in recognition of the firm's
growth, strategic account leadership and industry-leading employee
retention. Additionally, for the past four years, MWW Group has been
honored with the #1 ranking in the Holmes Report agency client satisfaction
survey. MWW Group achieved top rankings in the categories of account
leadership, strength of account team, creativity, strategy and planning,
and program execution.
MWW Group is one of the nation's top ten public relations agencies and
is known for its results-driven approach to public relations. The agency is
nationally recognized for its work in consumer marketing, corporate
communications, investor relations, publi
'/>"/>
SOURCE MWW Group Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine technology :1.
President Bush Ignores Americas Plea for Support of Stem Cell
Research2.
The Christopher and Dana Reeve Foundation Expresses Disappointment
Over President Bushs Veto of the Stem Cell Research Enhancement
Act3.
Dean: President Bush Has Turned His Back on the American People4.
Remarks by President Bush on Stem Cell Veto and Executive Order5.
BusinessWeek Article Highlights Promising Breakthrough Treatment
for Advanced Coronary Artery Disease6.
BusinessWeek Article Highlights Promising Breakthrough Treatment
for Advanced Coronary Artery Disease7.
Expert Opinion Highlights Avigens AV411 as Potential New
Therapeutic for Neuropathic Pain and Opioid Withdrawal8.
Positive Clinical Results for DG041 Lead Product Development
Highlights at deCODE R&D Event9.
Ambrilia Highlights Encouraging Data for its HIV Integrase
Inhibitor Program and Recent Developments at Annual Meeting10.
July Issue of Journal of Antimicrobial Chemotherapy Highlights
Study of Factive Tablets for Five-Day Treatment of
Community-Acquired Pneumonia11.
Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with
Electroporation DNA Delivery Technology and New Devices at Gene
Therapy Meeting